VENTRICULAR RATE CONTROL AND EXERCISE PERFORMANCE IN CHRONIC ATRIAL-FIBRILLATION - EFFECTS OF DILTIAZEM AND VERAPAMIL

被引:93
作者
LUNDSTROM, T
RYDEN, L
机构
[1] Department of Cardiology, Central Hospital, Skövde
关键词
D O I
10.1016/0735-1097(90)90461-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of two calcium channel blockers, diltiazem (270 mg/day) and verapamil (240 mg/day), were studied in 18 patients with chronic atrial fibrillation. During 24 h Holter electrocardiographic monitoring, mean ventricular rate (beats/min) decreased from 88 ± 14 with placebo to 76 ± 13 (p < 0.001) with diltiazem and 80 ± 11 (p < 0.01) with verapamil. Maximal symptom-limited exercise tolerance (W) increased from 127 ± 39 during the placebo period to 136 ± 42 (p < 0.01) with diltiazem and 137 ± 39 (p < 0.01) with verapamil. Ventricular rate and rate-pressure product were lower at rest and during exercise with diltiazem and verapamil than with placebo (p < 0.001), with the drugs being similarly effective. Ventricular rate at maximal exercise (beats/min) was 179 ± 13 with placebo compared with 159 ± 21 with diltiazem and 158 ± 23 with verapamil. Maximal oxygen uptake (ml/kg per min) was 22.3 ± 4.5 with placebo, 23.7 ± 4.9 (p < 0.05) with diltiazem and 22.9 ± 4.5 with verapamil (p = NS). Respiratory gas exchange anaerobic threshold was reached at a work load (W) of 76 ± 21 with placebo, 84 ± 27 (p < 0.05) with diltiazem and 85 ± 23 (p < 0.01) with verapamil. In conclusion, patients with chronic atrial fibrillation have modestly improved exercise tolerance with calcium channel blockade therapy. The dromotropic responses and the effects on physical performance are of similar magnitude for diltiazem and verapamil. © 1990.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 27 条
[1]  
ABERG H, 1972, ACTA MED SCAND, V191, P315
[2]   CLINICAL PHARMACOKINETICS OF VERAPAMIL IN PATIENTS WITH ATRIAL-FIBRILLATION [J].
ANDERSON, P ;
BONDESSON, U ;
SYLVEN, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (01) :49-57
[3]  
ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1
[4]   MAXIMAL EXERCISE TESTING AND GAS-EXCHANGE IN PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION [J].
ATWOOD, JE ;
MYERS, J ;
SULLIVAN, M ;
FORBES, S ;
FRIIS, R ;
PEWEN, W ;
CALLAHAM, P ;
HALL, P ;
FROELICHER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (03) :508-513
[5]   DILTIAZEM AND EXERCISE PERFORMANCE IN PATIENTS WITH CHRONIC ATRIAL-FIBRILLATION [J].
ATWOOD, JE ;
MYERS, JN ;
SULLIVAN, MJ ;
FORBES, SM ;
PEWEN, WF ;
FROELICHER, VF .
CHEST, 1988, 93 (01) :20-25
[6]  
ATWOOD JE, 1987, J AM COLL CARDIOL, V10, P314
[7]   EXERCISE HEART-RATES AT DIFFERENT SERUM DIGOXIN CONCENTRATIONS IN PATIENTS WITH ATRIAL-FIBRILLATION [J].
BEASLEY, R ;
SMITH, DA ;
MCHAFFIE, DJ .
BRITISH MEDICAL JOURNAL, 1985, 290 (6461) :9-11
[8]   A NEW METHOD FOR DETECTING ANAEROBIC THRESHOLD BY GAS-EXCHANGE [J].
BEAVER, WL ;
WASSERMAN, K ;
WHIPP, BJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 60 (06) :2020-2027
[9]  
BORG GAV, 1962, THESIS LUND, P39
[10]  
CORDAY E, 1961, DISTURBANCES HEART R, P207